|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2010-6-1
|
|
pubmed:abstractText |
The aim of this study was to determine whether a novel small molecule RVX-208 affects apolipoprotein (apo)A-I and high-density lipoprotein cholesterol (HDL-C) levels in vitro and in vivo.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
pubmed-author:BaileyDanaD,
pubmed-author:CampbellStevenS,
pubmed-author:ChaturSafiaS,
pubmed-author:ChiacchiaFabrizio SFS,
pubmed-author:GenestJacquesJ,
pubmed-author:GordonAllanA,
pubmed-author:HafianeAnouarA,
pubmed-author:HansenHenrik CHC,
pubmed-author:JahagirdarRaviR,
pubmed-author:JohanssonJanJ,
pubmed-author:KrimbouLarbiL,
pubmed-author:WagnerGregory SGS,
pubmed-author:WongNorman C WNC
|
|
pubmed:copyrightInfo |
Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2580-9
|
|
pubmed:dateRevised |
2010-9-3
|
|
pubmed:meshHeading |
pubmed-meshheading:20513599-Animals,
pubmed-meshheading:20513599-Apolipoprotein A-I,
pubmed-meshheading:20513599-Cells, Cultured,
pubmed-meshheading:20513599-Cercopithecus aethiops,
pubmed-meshheading:20513599-Cholesterol, HDL,
pubmed-meshheading:20513599-Cricetinae,
pubmed-meshheading:20513599-Disease Models, Animal,
pubmed-meshheading:20513599-Dose-Response Relationship, Drug,
pubmed-meshheading:20513599-Drug Administration Schedule,
pubmed-meshheading:20513599-Female,
pubmed-meshheading:20513599-Follow-Up Studies,
pubmed-meshheading:20513599-Hep G2 Cells,
pubmed-meshheading:20513599-Humans,
pubmed-meshheading:20513599-Macaca fascicularis,
pubmed-meshheading:20513599-Male,
pubmed-meshheading:20513599-Molecular Weight,
pubmed-meshheading:20513599-Probability,
pubmed-meshheading:20513599-Quinazolines,
pubmed-meshheading:20513599-Random Allocation,
pubmed-meshheading:20513599-Risk Assessment
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.
|
|
pubmed:affiliation |
Division of Cardiology, McGill University Health Center/Royal Victoria Hospital, Montréal, Québec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
In Vitro,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
